DOI QR코드

DOI QR Code

Proliferative and Inhibitory Activity of Siberian ginseng (Eleutherococcus senticosus) Extract on Cancer Cell Lines; A-549, XWLC-05, HCT-116, CNE and Beas-2b

  • Cichello, Simon Angelo (Institute of Nutrition and Food Science, School of Public Health, Kunming Medical University) ;
  • Yao, Qian (Yunnan Tumour Hospital) ;
  • Dowell, Ashley (Southern Cross Plant Science, Southern Cross University) ;
  • Leury, Brian (School of Veterinary and Agricultural Science, The University of Melbourne) ;
  • He, Xiao-Qiong (Institute of Nutrition and Food Science, School of Public Health, Kunming Medical University)
  • Published : 2015.06.26

Abstract

Siberian ginseng (Eleutherococcus senticosus) is used primarily as an adaptogen herb and also for its immune stimulant properties in Western herbal medicine. Another closely related species used in East Asian medicine systems i.e. Kampo, TCM (Manchuria, Korea, Japan and Ainu of Hokkaido) and also called Siberian ginseng (Acanthopanax senticosus) also displays immune-stimulant and anti-cancer properties. These may affect tumour growth and also provide an anti-fatigue effect for cancer patients, in particular for those suffering from lung cancer. There is some evidence that a carbohydrate in Siberian ginseng may possess not only immune stimulatory but also anti-tumour effects and also display other various anti-cancer properties. Our study aimed to determine the inhibitory and also proliferative effects of a methanol plant extract of Siberan ginseng (E. senticosus) on various cancer and normal cell lines including: A-549 (small cell lung cancer), XWLC-05 (Yunnan lung cancer cell line), CNE (human nasopharyngeal carcinoma cell line), HCT-116 (human colon cancer) and Beas-2b (human lung epithelial). These cell lines were treated with an extract from E. senticosus that was evaporated and reconstituted in DMSO. Treatment of A-549 (small cell lung cancer) cells with E. senticosus methanolic extract showed a concentration-dependent inhibitory trend from $12.5-50{\mu}g/mL$, and then a plateau, whereas at 12.5 and $25{\mu}g/mL$, there is a slight growth suppression in QBC-939 cells, but then a steady suppression from 50, 100 and $200{\mu}g/mL$. Further, in XWLC-05 (Yunnan lung cancer cell line), E. senticosus methanolic extract displayed an inhibitory effect which plateaued with increasing dosage. Next, in CNE (human nasopharyngeal carcinoma cell line) there was a dose dependent proliferative response, whereas in Beas-2 (human lung epithelial cell line), an inhibitory effect. Finally in colon cancer cell line (HCT-116) we observed an initially weak inhibitory effect and then plateau.

Keywords

Eleutherococcus senticosus;A-549 (small cell lung cancer);XWLC-05 (Yunnan lung cancer cell line)

References

  1. Ahn J, Um MY, Lee H, et al (2013). Eleutheroside E, an active component of Eleutherococcus senticosus, ameliorates insulin resistance in type 2 diabetic db/db Mice. Evid Based Complement Alternat Med, 2013, 934183.
  2. Asea A, Kaur P, Panossian A, et al (2013). Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts. Phytomedicine, 20, 1323-9. https://doi.org/10.1016/j.phymed.2013.07.001
  3. Bespalov VG, Aleksandrov VA, Iaremenko KV, et al (1992). The inhibiting effect of phytoadaptogenic preparations from bioginseng, Eleutherococcus senticosus and Rhaponticum carthamoides on the development of nervous system tumors in rats induced by N-nitrosoethylurea. Vopr Onkol, 38, 1073-80.
  4. Bohn B, Nebe CT, Birr C (1987). Flow-cytometric studies with Eleutherococcus senticosus extract as an immunomodulatory agent. Arzneimittelforschung, 37, 1193-6.
  5. Bone K (2007). The ultimate herbal compendium. a desktop guide for herbal prescriber. phytotherapy press, Warwick, QLD, Australia.
  6. Cicero AF, Derosa G, Brillante R, et al (2004). Effects of siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. Arch Gerontol Geriatr Suppl, 9, 69-73.
  7. SA Cichello, DP Begg, M Jois, et al (2013). Prevention of diet-induced obesity in C57BL/BJ mice with addition of 2% dietary green tea but not with cocoa or coffee to a high-fat diet. Mediterranean J Nutr Metabolism, 6, 233-8. https://doi.org/10.1007/s12349-013-0137-z
  8. Guo S, Liu Y, Lin Z, et al (2014). Effects of eleutheroside B and eleutheroside E on activity of cytochrome P450 in rat liver microsomes. BMC Complement Altern Med, 14, 1. https://doi.org/10.1186/1472-6882-14-1
  9. Ha ES, Hwang SH, Shin KS, et al (2004). Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation. Arch Pharm Res, 27, 217-24. https://doi.org/10.1007/BF02980109
  10. Hacker B, Medon PJ (1984). Cytotoxic effects of Eleutherococcus senticosus aqueous extracts in combination with N6-(delta 2-isopentenyl)-adenosine and 1-beta-D-arabinofuranosylcytosine against L1210 leukemia cells. J Pharm Sci, 73, 270-2. https://doi.org/10.1002/jps.2600730235
  11. He XQ, Cichello SA, Duan JL, Zhou J (2014). Canola oil influence on azoxymethane-induced colon carcinogenesis, hypertriglyceridemia and hyperglycemia in Kunming mice. Asian Pac J Cancer Prev, 15, 2477-83. https://doi.org/10.7314/APJCP.2014.15.6.2477
  12. Herb List (2012). Siberian ginseng retrieved from http://www.herbslist.net/siberian-ginseng-benefits.html
  13. Hibasami H, Fujikawa T, Takeda H, et al (2000). Induction of apoptosis by Acanthopanax senticosus HARMS and its component, sesamin in human stomach cancer KATO III cells. Oncol Rep, 7, 1213-6.
  14. Huang DB, Ran RZ, Yu ZF (2005). Effect of Acanthopanax senticosus injection on the activities of human tumor necrosis factor and natural killer cell in blood in the patients with lung cancer. Zhongguo Zhong Yao Za Zhi, 30, 621-4.
  15. Huang LZ, Huang BK, Ye Q, et al (2011). Bioactivity-guided fractionation for anti-fatigue property of Acanthopanax senticosus. J Ethnopharmacol, 133, 213-9. https://doi.org/10.1016/j.jep.2010.09.032
  16. Ichihara T, Wanibuchi H, Iwai S, et al (2002). White, but not red, ginseng inhibits progression of intestinal carcinogenesis in rats. Asian Pac J Cancer Prev, 3, 243-250.
  17. Kimura Y, Sumiyoshi M (2004). Effects of various Eleutherococcus senticosus cortex on swimming time, natural killer activity and corticosterone level in forced swimming stressed mice. J Ethnopharmacol, 95, 447-53. https://doi.org/10.1016/j.jep.2004.08.027
  18. Kuo J, Chen KW, Cheng IS, et al (2010). The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human. Chin J Physiol, 53, 105-11. https://doi.org/10.4077/CJP.2010.AMK018
  19. Lee S, Son D, Ryu J, et al (2004). Anti-oxidant activities of Acanthopanax senticosus stems and their lignan components. Arch Pharm Res, 27, 106-10. https://doi.org/10.1007/BF02980055
  20. Lee D, Park J, Yoon J (2012). Neuroprotective effects of Eleutherococcus senticosus bark on transient global cerebral ischemia in rats. J Ethnopharmacol, 139, 6-11. https://doi.org/10.1016/j.jep.2011.05.024
  21. Li C, Wang XY, Hu XW, Fang HT, Qiao SY (2008). Determination of eleutheroside B in antifatigue fraction of Acanthopanax senticosus by HPLC. Zhongguo Zhong Yao Za Zhi, 33, 2800-2.
  22. Li J, Wei Q, Zuo GW (2014). Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2/STAT5 signalling pathway in the TF-1/ Epo human leukemia cell line. Asian Pac J Cancer Prev, 15, 2453-9. https://doi.org/10.7314/APJCP.2014.15.6.2453
  23. Liu J, Cai SZ, Zhou Y, et al (2012). Senescence as a consequence of ginsenoside rg1 response on k562 human leukemia cell line. Asian Pac J Cancer Prev, 13, 6191-6. https://doi.org/10.7314/APJCP.2012.13.12.6191
  24. Sasanami T, Fujishima A, Moriya Y, et al (1982). NK activities in cancer patients-their modification by an immunopotentiator. Gan To Kagaku Ryoho, 9, 2186-92.
  25. Schaffler K, Wolf OT, Burkart M (2013). No benefit adding Eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study. Pharmacopsychiatry, 46, 181-90. https://doi.org/10.1055/s-0033-1347178
  26. Shan BE, Li QX, Liang WJ (2004). Experimental study on anti-tumor effects of cortex Acanthopanacis senticosus in vivo and in vitro. Zhongguo Zhong Xi Yi Jie He Za Zhi, 24, 55-8.
  27. Soo KH, Young PS, Kyoung KE, et al (2012). Acanthopanax senticosus has a heme oxygenase-1 signaling-dependent effect on Porphyromonas gingivalis lipopolysaccharide-stimulated macrophages. J Ethnopharmacol, 142, 819-28. https://doi.org/10.1016/j.jep.2012.06.006
  28. Soya H, Deocaris CC, Yamaguchi K, et al (2008). Extract from Acanthopanax senticosus harms (Siberian ginseng) activates NTS and SON/PVN in the rat brain. Biosci Biotechnol Biochem, 72, 2476-80. https://doi.org/10.1271/bbb.80209
  29. Tong L, Huang TY, Li JL (1994). Effects of plant polysaccharides on cell proliferation and cell membrane contents of sialic acid, phospholipid and cholesterol in S 180 and K 562 cells. Zhongguo Zhong Xi Yi Jie He Za Zhi, 14, 482-4.
  30. Yamazaki T, Shimosaka S, Sasaki H, et al (2007). (+)-Syringaresinol-di-O-beta-D-glucoside, a phenolic compound from Acanthopanax senticosus harms, suppresses proinflammatory mediators in SW982 human synovial sarcoma cells by inhibiting activating protein-1 and/or nuclear factor-kappaB activities. Toxicol In Vitro, 21, 1530-7. https://doi.org/10.1016/j.tiv.2007.04.016
  31. Yoon TJ, Yoo YC, Lee SW, et al (2004). Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. J Ethnopharmacol, 93, 247-53. https://doi.org/10.1016/j.jep.2004.03.052
  32. You ZM, Zhao L, Xia J, et al (2014). Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia $KG1{\alpha}$ cells. Asian Pac J Cancer Prev, 15, 1099-104. https://doi.org/10.7314/APJCP.2014.15.3.1099

Cited by

  1. Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer vol.15, pp.3, 2016, https://doi.org/10.1177/1534735416638738
  2. Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines vol.95, pp.44, 2016, https://doi.org/10.1097/MD.0000000000005210
  3. (Rupr. et Maxim.) Harms vol.40, pp.10, 2017, https://doi.org/10.1002/jssc.201601445
  4. Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer? vol.95, pp.35, 2016, https://doi.org/10.1097/MD.0000000000004517
  5. Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis pp.1552-695X, 2018, https://doi.org/10.1177/1534735418810799
  6. Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials vol.2018, pp.1741-4288, 2018, https://doi.org/10.1155/2018/7918258